These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9119023)

  • 21. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Nezami A; Luque I; Kimura T; Kiso Y; Freire E
    Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
    Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum.
    Wyatt DM; Berry C
    FEBS Lett; 2002 Feb; 513(2-3):159-62. PubMed ID: 11904142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme.
    Kesari P; Deshmukh A; Pahelkar N; Suryawanshi AB; Rathore I; Mishra V; Dupuis JH; Xiao H; Gustchina A; Abendroth J; Labaied M; Yada RY; Wlodawer A; Edwards TE; Lorimer DD; Bhaumik P
    Protein Sci; 2022 Apr; 31(4):882-899. PubMed ID: 35048450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
    Martins TM; Domingos A; Berry C; Wyatt DM
    Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target.
    Ramírez AR; Guerra Y; Otero A; García B; Berry C; Mendiola J; Hernández-Zanui A; Chávez Mde L
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):149-57. PubMed ID: 18471091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
    J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.
    Asojo OA; Gulnik SV; Afonina E; Yu B; Ellman JA; Haque TS; Silva AM
    J Mol Biol; 2003 Mar; 327(1):173-81. PubMed ID: 12614616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.
    Omara-Opyene AL; Moura PA; Sulsona CR; Bonilla JA; Yowell CA; Fujioka H; Fidock DA; Dame JB
    J Biol Chem; 2004 Dec; 279(52):54088-96. PubMed ID: 15491999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum.
    Klemba M; Goldberg DE
    Mol Biochem Parasitol; 2005 Oct; 143(2):183-91. PubMed ID: 16024107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.
    Banerjee R; Liu J; Beatty W; Pelosof L; Klemba M; Goldberg DE
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):990-5. PubMed ID: 11782538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
    Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
    Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
    Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
    J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional chimera of porcine pepsin prosegment and Plasmodium falciparum plasmepsin II.
    Parr-Vasquez CL; Yada RY
    Protein Eng Des Sel; 2010 Jan; 23(1):19-26. PubMed ID: 19910416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum.
    Xiao H; Tanaka T; Ogawa M; Yada RY
    Protein Eng Des Sel; 2007 Dec; 20(12):625-33. PubMed ID: 18073224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite.
    Westling J; Yowell CA; Majer P; Erickson JW; Dame JB; Dunn BM
    Exp Parasitol; 1997 Nov; 87(3):185-93. PubMed ID: 9371083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum Plasmepsin V (PfPMV): Insights into recombinant expression, substrate specificity and active site structure.
    Boonyalai N; Sittikul P; Yuvaniyama J
    Mol Biochem Parasitol; 2015 May; 201(1):5-15. PubMed ID: 25986559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping selectivity and specificity of active site of plasmepsins from Plasmodium falciparum using molecular interaction field approach.
    Kumar A; Ghosh I
    Protein Pept Lett; 2007; 14(6):569-74. PubMed ID: 17627598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.